Overcoming Pharmacy Barriers to Buprenorphine Access

Target Audience: This activity was developed to meet the needs of physicians, nurses, pharmacists and interprofessional healthcare providers. Discussion is designed to promote interactivity through an informal “round table” conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. In support of improving patient care, American […]

Exchange Session 4 – Implement/Sustain

Consider approaches to sustain MOUD and ensure continued access to high-quality care for our most challenged patients, including those who are pregnant, youth/adolescents, those with acute or chronic pain, and those electing to taper their dose.

Exchange Session 3 – Implement/Sustain

Review considerations for MOUD initiation and follow-up, including lab guidelines, and clinical management of patients with continued use (e.g., fentanyl, novel synthetic opioids), overdose risk, poly-substance use, and comorbid mental health conditions.